𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab improves quality of life in patients with Crohn's disease

✍ Scribed by Dr. Gary R. Lichtenstein; Mohan Bala; Chenglong Han; Kimberly DeWoody; Thomas Schaible


Book ID
110086020
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
134 KB
Volume
8
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sustained improvement of health-related
✍ Francesc Casellas; Luis Rodrigo; Pilar NiΓ±o; Carmen Pantiga; Sabino Riestra; Jua πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 2 views

## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo

Rasagiline improves quality of life in p
✍ Kevin M. Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; T πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 1 views

The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P